Tandem Diabetes Care, Inc.
Could not find a ticker for this position, may be a filing error
A maker of insulin pumps and automated insulin delivery systems for people with type 1 and type 2 diabetes. Its t:slim X2 and Tandem Mobi pumps, powered by the Control-IQ+ algorithm, work with continuous glucose monitors to help predict and prevent high and low blood sugar events. The company serves nearly 500,000 people across more than 25 countries.
1.5% Convertible Senior Notes due 2029
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.